Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Accendra Health (ACH) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Accendra Health (ACH) over the last 16 years, with Q3 2025 value amounting to -$144.7 million.

  • Accendra Health's Income towards Parent Company fell 93106.69% to -$144.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 240126.09%. This contributed to the annual value of -$414.9 million for FY2024, which is 69781.38% down from last year.
  • As of Q3 2025, Accendra Health's Income towards Parent Company stood at -$144.7 million, which was down 93106.69% from -$785.2 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Income towards Parent Company ranged from a high of $39.3 million in Q1 2022 and a low of -$785.2 million during Q2 2025
  • Over the past 4 years, Accendra Health's median Income towards Parent Company value was -$24.4 million (recorded in 2023), while the average stood at -$96.7 million.
  • As far as peak fluctuations go, Accendra Health's Income towards Parent Company skyrocketed by 11061.12% in 2023, and later tumbled by 569542.24% in 2024.
  • Accendra Health's Income towards Parent Company (Quarter) stood at -$66.7 million in 2022, then surged by 110.61% to $7.1 million in 2023, then crashed by 5695.42% to -$396.0 million in 2024, then skyrocketed by 63.47% to -$144.7 million in 2025.
  • Its Income towards Parent Company stands at -$144.7 million for Q3 2025, versus -$785.2 million for Q2 2025 and -$25.0 million for Q1 2025.